Abstract
Background
Preoperative chemoradiation can potentially improve outcomes in patients with pancreatic cancer. This study addresses its effect on staging pancreatic cancer with multidetector computed tomography (MDCT).
Methods
Fifty-five patients underwent a dual-phase MDCT pancreas protocol for proved pancreatic cancer. Of these, 16 patients underwent preoperative chemoradiation. Three radiologists independently reviewed images to assess for locally advanced disease, liver and peritoneal metastases on baseline studies of all 55 patients, and on follow-up preoperative studies for the 16 patients receiving preoperative therapy. Overall score for resectability was graded on a scale from 1 to 5 (1, definitely resectable; 5. definitely unresectable). Receiver operating characteristic curves and weighted (κ statistics were determined.
Results
The areas under the receiver operating characteristic curves for readers 1, 2, and 3 were 0.98, 0.96, and 0.90, respectively. Weighted κ values for reader 1 versus reader 2, reader 1 versus reader 3, and reader 2 versus reader 3 were 0.90, 0.57, and 0.54, respectively. Interpreting scores of 1 to 3 for resectability as resectable disease, the mean values for sensitivity, specificity, negative predictive value, positive predictive value, and accuracy were 0.92, 0.91, 0.74, 0.98, and 0.92 respectively.
Conclusion
The negative predictive value for MDCT for identifying unresectable pancreatic cancer in the setting of preoperative therapy is comparable to that reported in the absence of neoadjuvant therapy.
Similar content being viewed by others
References
Jemal A, Tiwari RC, Murray T, et al. (2004) Cancer statistics, 2004. CA Cancer J Clin 54:8–29
Trede M, Schwall G, Saeger H-D (1990) Survival after pancreatoduodenectomy. Ann Surg 211:447–458
Lowenfels A, Maisonneuve P, Boyle P (1998) Epidemiology of pancreatic cancer. In: Howard J, Idezuki Y, Ihse I, Prinz R, eds. Surgical disease of the pancreas, 3rd ed. Baltimore: Williams & Wilkins, 433–437
Douglass HJ, Kim S, Meropol N (1997) Neoplasms of the exocrine pancreas. In: Holland J, Frei EI, Bast RJ, eds. Cancer medicine, 4th ed. Baltimore: Williams & Wilkins, 1989–2018
Evans DB, Abbruzzese JL, Willett CG (2001) Cancer of the pancreas. In: DeVita VT, Hellman S, Rosenberg SA, eds. Cancer, principles and practice of oncology, 6th ed. Philadelphia: Lippincott Williams & Wilkins, 1126–1161
Staley CA, Lee JE, Cleary KR, et al. (1996) Preoperative chemoradiation, pancreaticoduodenectomy, and intraoperative radiation therapy for adenocarcinoma of the pancreatic head. Am J Surg 171:115–124
Neoptolemos JP, Dunn JA, Stocken DD, et al. (2001) Adjuvant chemoradiotherapy and chemotherapy in resectable pancreatic cancer: a randomised controlled trial. Lancet 358:1576–1585
Kalser MH, Ellenberg SS (1985) Pancreatic cancer. Adjuvant combined radiation and chemotherapy following curative resection. Arch Surg 120:899–903
Burris HA III, Moore MJ, Andersen J, et al. (1997) Improvements in survival and clinical benefit with gemcitabine as first-line therapy for patients with advanced pancreas cancer: a randomized trial. J Clin Oncol 15:2403–2413
Mason KA, Milas L, Hunter NR, et al. (1999) Maximizing therapeutic gain with gemcitabine and fractionated radiation. Int J Radiat Oncol Biol Phys 44:1125–1135
McGinn CJ, Zalupski MM (2003) Radiation therapy with once-weekly gemcitabine in pancreatic cancer: current status of clinical trials. Int J Radiat Oncol Biol Phys 56:10–15
Breslin TM, Janjan NA, Lee JE, et al. (1998) Neoadjuvant chemoradiation for adenocarcinoma of the pancreas. Front Biosci 3:E193–E203
Evans DB, Pisters PW, Lee JE, et al. (1998) Preoperative chemoradiation strategies for localized adenocarcinoma of the pancreas. J Hepatobiliary Pancreat Surg 5:242–250
Pisters PW, Hudec WA, Lee JE, et al. (2000) Preoperative chemoradiation for patients with pancreatic cancer: toxicity of endobiliary stents. J Clin Oncol 18:860–867
Janjan NA, Crane CN, Feig BW, et al. (2000) Prospective trial of preoperative concomitant boost radiotherapy with continuous infusion 5-fluorouracil for locally advanced rectal cancer. Int J Radiat Oncol Biol Phys 47:713–718
Breslin TM, Hess KR, Harbison DB, et al. (2001) Neoadjuvant chemoradiotherapy for adenocarcinoma of the pancreas: treatment variables and survival duration. Ann Surg Oncol 8:123–132
Wolff RA, Evans DB, Gravel DM, et al. (2001) Phase I trial of gemcitabine combined with radiation for the treatment of locally advanced pancreatic adenocarcinoma. Clin Cancer Res 7:2246–2253
Crane C, Janjan N, Evans D, et al. (2001) Toxicity and efficacy of concurrent gemcitabine and radiotherapy for locally advanced pancreatic cancer. Int J Gastrointest Cancer 29:9–18
Wolff RA, Evans DB, Crane CH, et al. (2002) Initial results of preoperative gemcitabine (GEM)–based chemoradiation for resectable pancreatic adenocarcinoma. Orlando, FL: American Society of Clinical Oncology
Diehl SJ, Lehmann KJ, Sadick M, et al. (1998) Pancreatic cancer: value of dual-phase helical CT in assessing resectability. Radiology 206:373–378
Valls C, Andia E, Sanchez A, et al. (2002) Dual-phase helical CT of pancreatic adenocarcinoma: assessment of resectability before surgery. AJR 178:821–826
McCarthy MJ, Evans J, Sagar G, Neoptolemos JP (1998) Prediction of resectability of pancreatic malignancy by computed tomography. Br J Surg 85:320–325
Loyer EM, David CL, Dubrow RA, et al. (1996) Vascular involvement in pancreatic adenocarcinoma: reassessment by thin- section CT. Abdom Imaging 21:202–206
Kim T, Murakami T, Takahashi S, et al. (1999) Pancreatic CT imaging: effects of different injection rates and doses of contrast material. Radiology 212:219–225
National Comprehensive Cancer Network I (2004) Clinical practice guidelines in oncology: pancreatic adenocarcinoma. National Comprehensive Cancer Network, PA, USA, http://www.nccn.org/professionals/physician_gls/PDF/pancreatic.pdf
Exocrine pancreas. In: Greene F, Page D, Fleming I, et al. (eds) (2002) AJCC cancer staging manual, 6th ed. New York: Springer-Verlag, 157–164
Freeny PC, Traverso LW, Ryan JA (1993) Diagnosis and staging of pancreatic adenocarcinoma with dynamic computed tomography. Am J Surg 165:600–606
Bluemke DA, Cameron JL, Hruban RH, et al. (1995) Potentially resectable pancreatic adenocarcinoma: spiral CT assessment with surgical and pathologic correlation. Radiology 197:381–385
Tabuchi T, Itoh K, Ohshio G, et al. (1999) Tumor staging of pancreatic adenocarcinoma using early- and late-phase helical CT. AJR 173:375–380
Warshaw AL, Fernandez-del Castillo C (1992) Pancreatic carcinoma. N Engl J Med 326:455–465
van Delden OM, de Wit LT, Nieveen van Dijkum EJ, et al. (1998) Laparoscopic ultrasonography for abdominal tumor staging. Eur Radiol 8:1405–1408
Jimenez RE, Warshaw AL, Fernandez-Del Castillo C (2000) Laparoscopy and peritoneal cytology in the staging of pancreatic cancer. J Hepatobiliary Pancreat Surg 7:15–20
Author information
Authors and Affiliations
Corresponding author
Additional information
An erratum to this article can be found online at http://dx.doi.org/10.1007/s00261-011-9702-4
Rights and permissions
About this article
Cite this article
Tamm, E.P., Loyer, E.M., Faria, S. et al. Staging of pancreatic cancer with multidetector CT in the setting of preoperative chemoradiation therapy. Abdom Imaging 31, 568–574 (2006). https://doi.org/10.1007/s00261-005-0194-y
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00261-005-0194-y